Cite
HARVARD Citation
Bouchahda, M. et al. (2016). Early tumour response as a survival predictor in previously- treated patients receiving triplet hepatic artery infusion and intravenous cetuximab for unresectable liver metastases from wild-type KRAS colorectal cancer. European journal of cancer. pp. 163-172. [Online].